AREDS Eye Vitamins

AREDS Eye Vitamins Fight Macular Degeneration

In 2001, the National Eye Institute released the results of a clinical trial designed to investigate the risk factors for age-related macular degeneration and test the effect of zinc and antioxidants on the progression of AMD. That trial – the Age-Related Eye Disease Study (AREDS) – concluded that the formula of vitamins and minerals administered to participants reduce the risk of age-related macular degeneration by up to 25%. The formula in AREDS eye vitamins is composed of the following key vitamins and minerals:

• Vitamin A
• Beta-Carotene
• Vitamin C
• Vitamin E
• Zinc
• Copper

The same formula that got results in the NEI study is used in VisiVite AREDS eye vitamins. For smokers, VisiVite has a special smokers formula that replaces Beta-Carotene with Lutein.

The Future of AREDS Eye Vitamins
Further research has indicated that Omega-3 fatty acids and anti-inflammatories may also have an effect on AMD. The National Institutes for Health has announced a second study, AREDS 2, to investigate these claims. We have predicted the outcome of AREDS 2 and have made several modifications to the formula of our AREDS eye vitamins based on what we believe to be the most successful components of the new study. VisiVite Premier Ocular Formula No. 2 contains the macular xanthophylls Lutein and Zeaxanthin, carotenoids that protect the eyes from HEV light and oxidation.

VisiVite Premier Ocular Formula No. 2 is the blend of AREDS eye vitamins we recommend to anyone suffering from advanced macular degeneration or individuals suffering from large drusen, pigmentation in the retina or geographic atrophy. Because Formula No. 2 has no Beta-Carotene, it is safe for smokers and non-smokers alike.

In addition to the selection of AREDS eye vitamins at VisiVite, we offer a selection of unique macular degeneration products designed to slow the progress of AMD. While VisiVite cannot restore vision, the AREDS formula has been shown to slow the progress of macular degeneration in some patients.